-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Reiterates Buy on Edwards Lifesciences, Raises Price Target to $118

Benzinga·11/05/2026 15:35:50
Listen to the news
Truist Securities analyst Richard Newitter reiterates Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $113 to $118.